Amgen's MariTide phase 2 trial - 20% weight loss, no plateau, once a month injection

Apparently the market thinks 20% is weak sauce, shares getting killed
 
Apparently the market thinks 20% is weak sauce, shares getting killed
20% is quite good. While it's about the same as for tirzepatide, if they offer it for 10-50% less than Zepbound and offer once per month dosing, there is a lot of money to be made. With that said, while I invest in the stock market, I never pick winners and only invest in S & P 500 index funds or bonds; I never try to pick winners. I follow the advice of Jack Bogle: If you want to find a needle in a haystack, buy the haystack.
 
They had some pretty alarming bone loss news recently, I wouldn't get too excited.
One won't have to lose fat or muscle in order to lose weight. Maybe keeping the fat will enable the drug to avoid causing the GLP-1 chills from which I now suffer. Bones are overrated: Many invertebrates manage to do just fine without them.
 
One won't have to lose fat or muscle in order to lose weight. Maybe keeping the fat will enable the drug to avoid causing the GLP-1 chills from which I now suffer. Bones are overrated: Many invertebrates manage to do just fine without them.
Have u tried to be on test C or E while on your weight loss journey with GLP1s?
 
Back
Top